Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

M. Ruella, S. S. Kenderian, O. Shestova, M. Klichinsky, J. J. Melenhorst, M. A. Wasik, S. F. Lacey, C. H. June, S. Gill

Research output: Contribution to journalLetterpeer-review

49 Scopus citations
Original languageEnglish (US)
Pages (from-to)246-248
Number of pages3
JournalLeukemia
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this